MEIRAGTX
MeiraGTx is committed to the development and commercialization of innovative gene therapy products to transform the lives of patients suffering from acquired and inherited disorders. We are a vertically integrated, clinical stage gene therapy company with five ongoing clinical programs and a broad pipeline of preclinical and research programs. We have core capabilities in viral vector design and optimization and gene therapy manufacturing as well as a potentially transformative gene regulation ... technology. Led by an experienced management team, we have taken a portfolio approach by licensing, acquiring and developing technologies that give us depth across both product candidates and indications. Though initially focusing on the eye, salivary gland and central nervous system, we intend to expand our focus in the future to develop additional gene therapy treatments for patients suffering from a range of serious diseases.
MEIRAGTX
Industry:
Biotechnology Health Care Therapeutics
Founded:
2015-03-20
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.meiragtx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
82.66 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-10-05 | Vector Neurosciences | Vector Neurosciences acquired by MeiraGTx | N/A |
Investors List
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Debt - MeiraGTx
Essex Bio-Technology
Essex Bio-Technology investment in Series B - MeiraGTx
UCL Technology Fund
UCL Technology Fund investment in Venture Round - MeiraGTx
AlbionVC
AlbionVC investment in Venture Round - MeiraGTx
Key Employee Changes
| Date | New article |
|---|---|
| 2020-08-05 | MeiraGTx Names Immunovant’s Zeldin as Its Chief Medical Officer |
Official Site Inspections
http://www.meiragtx.com Semrush global rank: 1.04 M Semrush visits lastest month: 32.44 K
- Host name: 153.95.193.35.bc.googleusercontent.com
- IP address: 35.193.95.153
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "MeiraGTx"
Next-Gen Genetic Medicine - MeiraGTx
Feb 22, 2025 MeiraGTx is a clinical-stage genetic medicine company committed to harnessing the full potential of genetic therapies for both rare and prevalent diseases. MeiraGTx is pioneering transformative technologies that allow precision control of gene expression. Our riboswitch …See details»
MeiraGTx - Crunchbase Company Profile & Funding
MeiraGTx's research and development efforts primarily revolve around gene therapy, a cutting-edge approach that involves modifying or replacing faulty …See details»
Our Team - MeiraGTx
Giroux joined MeiraGTx from Sarissa Capital Management LP, an activist healthcare hedge fund, where he was a partner from March 2014 to March 2015. Prior to Sarissa Capital Management LP, Mr. Giroux was a founding partner and healthcare portfolio manager of Meadowvale …See details»
MeiraGTx Org Chart + Executive Team - The Official Board
Organizational Chart of MeiraGTx. MeiraGTx Org Chart www.meiragtx.com. has 17 executives +1 646 490 2965; Add an executive. MeiraGTx (MGTX) News . Anything missing? We search for you. Print or download . CEO & Director. Alexandria Forbes. Move. Chairman of the Board. …See details»
MeiraGTx Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 MeiraGTx has 5 employees across 4 locations and $33.28 m in annual revenue in FY 2024. See insights on MeiraGTx including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
MeiraGTx
MeiraGTxSee details»
MeiraGTx Holdings (MGTX) Company Profile & Description - Stock …
2 days ago MeiraGTx Holdings plc, a clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative …See details»
MeiraGTx - Contacts, Employees, Board Members, Advisors
Organization. MeiraGTx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. ... MeiraGTx has 10 board members and advisors, including Martin Indyk. Martin Indyk Board Member Feb 2019. Debra …See details»
MeiraGTx - Leadership Team - The Org
The Leadership Team at MeiraGTx is responsible for setting the strategic direction and vision of the company, overseeing the development and integration of innovative gene therapies. This team collaborates to drive operational excellence, ensure financial health, and navigate …See details»
MeiraGTx company information, funding & investors | Dealroom.co
Mar 1, 2015 MeiraGTx, a gene therapy company with end-to-end capabilities in gene therapy discovery, development and gmp manufacturing. Here you'll find information about their funding, investors and team.See details»
Board of Directors - MeiraGTx
Alexandria Forbes, Ph.D. has served as our President, Chief Executive Officer and member of our Board of Directors since March 2015.Prior to founding MeiraGTx, Dr. Forbes served as Senior Vice President of Commercial Operations at Kadmon Holdings, Inc., a biopharmaceutical …See details»
Alexandria Forbes
Alexandria Forbes on the 2023 50 Over 50 - Innovation. At age 50, Alexandria Forbes founded MeiraGTx, a gene therapy company with six clinical programs and innovative technology to control genes ...See details»
MeiraGTx - Funding, Financials, Valuation & Investors - Crunchbase
MeiraGTx is registered under the ticker NASDAQ:MGTX . Their stock opened with $15.00 in its Jun 7, 2018 IPO. MeiraGTx is funded by 6 investors. Sanofi and Perceptive Advisors are the most recent investors. MeiraGTx has acquired Vector Neurosciences on Oct 5, 2018.See details»
Meiragtx - Facebook
Sep 28, 2021 MeiraGTx is excited to be participating in the 2nd Sofia Sees Hope Scavenger Hunt! Founded in 2014, Sofia Sees Hope is a nonprofit patient advocacy organization dedicated to generating awareness, raising funds for research, and providing support, education and …See details»
Sanofi pays $30M for first look at MeiraGTx data, shot at deals
Oct 31, 2023 MeiraGTx sold 4 million ordinary shares for $7.50 apiece, providing access to a first look at data from programs in immunology and inflammation, central nervous disorders and GLP-1 and other gut ...See details»
Who Owns MeiraGTx – CanvasBusinessModel.com
Dec 19, 2024 Who Owns MeiraGTx: In the rapidly evolving landscape of biotechnology and gene therapy, MeiraGTx has emerged as a key player in the field. Founded on a mission to develop innovative treatments for a variety of genetic disorders, the ownership of MeiraGTx is …See details»
A Brief History of MeiraGTx – CanvasBusinessModel.com
Dec 19, 2024 [cbm_blg_rlnkng]MeiraGTx is a renowned biotechnology company at the forefront of gene therapy innovation. Founded in 2015, the company has quickly made a name for itself in the field by developing cutting-edge treatments for genetic disorders and rare diseases. With a …See details»
Mission, Vision & Core Values of MeiraGTx
Dec 19, 2024 MeiraGTx Mission, Vision & Core Values. At MeiraGTx, our mission is to develop innovative gene therapies to potentially transform the lives of patients suffering from genetic disorders. With a vision to be a global leader in the field of gene therapy, we are committed to …See details»
MeiraGTx Receives Rare Pediatric Disease Designation from FDA …
Jan 22, 2025 MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage genetic medicines company with a broad pipeline of late-stage clinical programs supported by end-to-end manufacturing capabilities. MeiraGTx has internal plasmid production for GMP, two GMP viral …See details»
Posters & Publications - MeiraGTx
AI-driven promoter optimization at MeiraGTx 2022 ESGCT. Liu et al. Poster Presentation. A CNS-targeted gene therapy for the treatment of obesity 2022 ESGCT. Sullivan, et al. Poster Presentation. Development of an in-vitro testing platform for AAV-UPF1 gene therapy to treat …See details»